T(1)–T(2) molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents

BACKGROUND: The development of T(1)–T(2) dual contrast agent (CA) favors the visualization of the lesion in a more accurate and reliable manner by magnetic resonance imaging (MRI). The relaxivity and the interference between T(1) and T(2) CA are the main concerns for their design. METHODS: In this w...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingjing, You, Jia, Wu, Chen, Dai, Yue, Shi, Meilin, Dong, Lina, Xu, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091481/
https://www.ncbi.nlm.nih.gov/pubmed/30127609
http://dx.doi.org/10.2147/IJN.S168660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091481/
https://www.ncbi.nlm.nih.gov/pubmed/30127609
http://dx.doi.org/10.2147/IJN.S168660

Ejemplares similares